Journal article
Rotavirus immunization: Global coverage and local barriers for implementation
- Abstract:
-
Background
Rotavirus (RV) is a major agent of gastroenteritis and an important cause of child death worldwide. Immunization (RVI) has been available since 2006. the Federation of International Societies of Gastroenterology Hepatology and Nutrition (FISPGHAN) identified RVI as a top priority for the control of diarrheal illness. A FISPGHAN working group on acute diarrhea aimed at estimating the current RVI coverage and identifying barriers to implementation worldwide.
Methods
A survey was distributed to national experts in infectious diseases and vaccinations, and health-care authorities (March 2015 -April 2016), collecting information on local recommendations, costs and perception of barriers to implementation.
Findings
RVI is recommended in 27/49 countries (55%) participating in the survey. Although five countries have recommended RVI since 2006, a large number (16, 33%) included RVI in a National Immunization Schedule between 2012 and 2014. The costs of vaccination are covered by the government (39%), by the GAVI Alliance (10%) or public and private insurance (8%) in some countries. However, in most cases, immunization is paid by families (43%). Elevated costs (49%) and the limited perception of RV illness severity by the families (47%) and public-health authorities (37%) are the major barriers to large-scale RVI programs.
Interpretation
After 10 years since its introduction, the implementation of RVI is still unacceptably low and should remain a major target for global public health. Barriers to implementation vary according to setting. Nevertheless, public health authorities should promote education for caregivers and health-care providers and interact with local health authorities in order to implement RVI
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 1.1MB, Terms of use)
-
- Publisher copy:
- 10.1016/j.vaccine.2017.01.082
Authors
- Publisher:
- Elsevier
- Journal:
- Vaccine More from this journal
- Volume:
- 35
- Issue:
- 12
- Pages:
- 1637-1644
- Publication date:
- 2017-02-01
- Acceptance date:
- 2017-01-27
- DOI:
- ISSN:
-
0264-410X and 1873-2518
- Keywords:
- Pubs id:
-
pubs:684183
- UUID:
-
uuid:f6c12fbc-0b8a-4931-9e87-8e9202519d61
- Local pid:
-
pubs:684183
- Source identifiers:
-
684183
- Deposit date:
-
2017-04-04
Terms of use
- Copyright holder:
- Elsevier Ltd
- Copyright date:
- 2017
- Notes:
- © 2017 Elsevier Ltd. All rights reserved.
If you are the owner of this record, you can report an update to it here: Report update to this record